Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Refining prognostication in systemic AL amyloidosis: limited value of dFLC.
Khwaja J, Ravichandran S, Bomsztyk J, Cohen O, Foard D, Martinez-Naharro A, Venneri L, Fontana M, Whelan C, Hawkins PN, Gillmore JD, Lachmann HJ, Mahmood S, Wechalekar A. Khwaja J, et al. Among authors: foard d. Amyloid. 2024 Dec;31(4):353-355. doi: 10.1080/13506129.2024.2406845. Epub 2024 Sep 23. Amyloid. 2024. PMID: 39311543 No abstract available.
A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.
Carter JP, Foard D, Rannigan L, Aliaz K, Mahmood S, Sachchithanantham S, Fontana M, Quarta C, Martinez De Azcona Naharro A, Youngstein T, Rezk T, Wechalekar A, Whelan C, Lachmann H, Hawkins P, Gillmore J, Lane T. Carter JP, et al. Among authors: foard d. Amyloid. 2017 Mar;24(sup1):72-73. doi: 10.1080/13506129.2017.1295944. Amyloid. 2017. PMID: 28434320 No abstract available.
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Ravichandran S, Cohen OC, Law S, Sachchithanantham S, Mahmood S, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD. Ravichandran S, et al. Among authors: foard d. Br J Haematol. 2021 Aug;194(3):587-597. doi: 10.1111/bjh.17636. Epub 2021 Jun 29. Br J Haematol. 2021. PMID: 34189728
Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
Ravichandran S, Law S, Mahmood S, Wisniowski B, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD. Ravichandran S, et al. Among authors: foard d. Leukemia. 2022 Apr;36(4):1180-1184. doi: 10.1038/s41375-021-01497-7. Epub 2022 Jan 6. Leukemia. 2022. PMID: 34987193 Free PMC article. No abstract available.
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis.
Cohen OC, Sathyanath A, Petrie A, Ravichandran S, Law S, Manwani R, Foard D, Sachchithanantham S, Mahmood S, Martinez-Naharro A, Fontana M, Whelan CJ, Hawkins PN, Lachmann HJ, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: foard d. Heart. 2022 Sep 26;108(20):1616-1622. doi: 10.1136/heartjnl-2021-320703. Heart. 2022. PMID: 35764371
43 results